JPRN-UMIN000010205已完成未知
Prediction of therapeutic efficacy of infliximab for refractory ulcerative colitis by analyzing and measuring serum concentration of cytokines and infliximab - Prediction of therapeutic efficacy of IFX for refractory UC by measuring serum cytokines and IFX
School of Medicine, Keio University Division Gastroenterology and Hepatology, Department of Internal Medicine0 个研究点目标入组 100 人开始时间: 2013年3月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who refuse the induction infliximab therapy or those who don't agree with participating in this study after sufficient written explanation.
研究者
相似试验
已完成
不适用
Study for predictors of response to infliximab therapy for ulcerative colitislcerative colitisJPRN-UMIN000007256Kanagawa Crohn Disease Treatment Study Group50
尚未招募
4 期
Pro-RAPIDCrohn's Disease2023-507352-72-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)50
尚未招募
4 期
Prospective Analysis of Pharmacokinetic Infliximab data in Paediatric Inflammatory Bowel Disease patientsCrohn's diseaseNL-OMON51805Erasmus MC, Universitair Medisch Centrum Rotterdam49
进行中（未招募）
1 期
Prospective Analysis of Pharmacokinetic Infliximab data in Paediatric Inflammatory Bowel Disease patients (Pro-RAPID)Crohn's DiseaseCTIS2023-507352-72-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)50
已完成
不适用
Study of the pharmacokinetics of Infliximab (IFX) in moderate to severe Ulcerative ColitisInflammatory Bowel Disease10017969Ulcerative ColitisNL-OMON37516Academisch Medisch Centrum20